Evidence map›Paper›PMID 23824191›Full record

ArticleThe Journal of biological chemistry2013

T-cadherin is essential for adiponectin-mediated revascularization.

Jennifer L Parker-Duffen, Kazuto Nakamura, Marcy Silver, Ryosuke Kikuchi, Ulrich Tigges, Sumiko Yoshida, Martin S Denzel, Barbara Ranscht, Kenneth Walsh

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 166 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Observational
  7. Review
  8. Article
  9. Article
  10. T-Cadherin (International journal of molecular sciences · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Adiponectin suppresses stiffness-dependent, profibrotic activation of lung fibroblasts.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  18. Article
  19. Article
  20. The Role of Adipokines in the Control of Pituitary Functions.Animals : an open access journal from MDPI · 2024
    Review

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jennifer L Parker-DuffenWhitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Kazuto Nakamura
Marcy Silver
Ryosuke Kikuchi
Ulrich Tigges
Sumiko Yoshida
Martin S Denzel
Barbara Ranscht
Kenneth Walsh
Whitaker Center for Science and the Arts · USSanford Burnham Prebys Medical Discovery Institute · USCardiovascular Institute of the South · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ELENA B PASQUALE · 1985 to 2026
$107.2M
Redox regulation in Endothelial Progenitor CellsP01HL081587 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WALSH, KENNETH · 2005 to 2015
$21.5M
SIRT1, Polyphenols, and Endothelial OxidantsP01HL068758 · NHLBI · BOSTON MEDICAL CENTER · PI RUDERMAN, NEIL B · 2003 to 2013
$14.1M
TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
Training Program in Cardiovascular Biology: Pre-DoctoralT32HL007969 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAVID, KATYA · 2003 to 2019
$3.2M
Muscle loss and metabolic dysfunction associated with agingR01AG034972 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WALSH, KENNETH · 2010 to 2014
$1.6M
Role of T-Cadherin in Adiponection-mediated cardiovascular functionsR21HL102680 · NHLBI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RANSCHT, BARBARA · 2010 to 2011
$525k
NHLBI NIH HHS HL007969NHLBI NIH HHS HL102680NHLBI NIH HHS HL68758NHLBI NIH HHS HL81587NHLBI NIH HHS P01 HL068758NHLBI NIH HHS P01 HL081587NHLBI NIH HHS R21 HL102680NHLBI NIH HHS T32 HL007969NIA NIH HHS AG34972NIA NIH HHS R01 AG034972NIGMS NIH HHS GM008541NIGMS NIH HHS T32 GM008541
6 · The paper itself

Abstract

Adipose tissue secretes protein factors that have systemic actions on cardiovascular tissues. Previous studies have shown that ablation of the adipocyte-secreted protein adiponectin leads to endothelial dysfunction, whereas its overexpression promotes wound healing. However, the receptor(s) mediating the protective effects of adiponectin on the vasculature is not known. Here we examined the role of membrane protein T-cadherin, which localizes adiponectin to the vascular endothelium, in the revascularization response to chronic ischemia. T-cadherin-deficient mice were analyzed in a model of hind limb ischemia where blood flow is surgically disrupted in one limb and recovery is monitored over 28 days by laser Doppler perfusion imaging. In this model, T-cadherin-deficient mice phenocopy adiponectin-deficient mice such that both strains display an impaired blood flow recovery compared with wild-type controls. Delivery of exogenous adiponectin rescued the impaired revascularization phenotype in adiponectin-deficient mice but not in T-cadherin-deficient mice. In cultured endothelial cells, T-cadherin deficiency by siRNA knockdown prevented the ability of adiponectin to promote cellular migration and proliferation. These data highlight a previously unrecognized role for T-cadherin in limb revascularization and show that it is essential for mediating the vascular actions of adiponectin.

Indexed as

AdiponectinAnimalsCadherinsEndothelium, VascularGene Knockdown TechniquesHindlimbIschemiaMiceMice, KnockoutNeovascularization, PhysiologicAdiponectinCadherinsH-cadherinAdiponectinAdipoR1AdipoR2AngiogenesisIschemiaPeripheral Vascular DiseaseSkeletal MuscleT-cadherinVascular Biology

Identifiers

PMID23824191
PMCPMC3750183
OpenAlexW2082673878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.